The relationships among clinician delay of diagnosis of breast cancer and tumor size, nodal status, and stage

    Research output: Contribution to journalArticle

    18 Citations (Scopus)

    Abstract

    Background: The objective of this study was to determine the impact of delay of diagnosis by clinicians on breast cancer prognostic factors and survival. Methods: The medical records of patients whose breast cancer diagnosis was delayed by clinicians were reviewed. Data collected included primary tumor diameter, number of positive lymph nodes, tumor grade, pathologic stage, length of diagnostic delay, and follow-up status. Data were analyzed for correlations between prognostic factors and length of delay. The Fisher exact test was used to correlate delay and stage with survival. Results: Forty patients had delays from 3 to 36 months. There were no significant correlations between delay and natural log of primary tumor diameter (r = -.16, P = .33), number of positive lymph nodes (r = .22, P = .90), tumor grade (R = -.16, P = .36), or pathologic stage (R = -.09, P = .59). A higher stage correlated with decreased survival (P = .03), but delay did not. Conclusions: Clinician diagnostic delays of up to 36 months did not correlate with worsening prognostic factors or with survival rates.

    Original languageEnglish (US)
    Pages (from-to)506-508
    Number of pages3
    JournalAmerican Journal of Surgery
    Volume192
    Issue number4
    DOIs
    StatePublished - Oct 2006

    Fingerprint

    Breast Neoplasms
    Survival
    Neoplasms
    Lymph Nodes
    Delayed Diagnosis
    Medical Records
    Survival Rate

    Keywords

    • Breast cancer
    • Delay of diagnosis

    ASJC Scopus subject areas

    • Surgery

    Cite this

    @article{ace43281827f4072869b690b09e2dcd3,
    title = "The relationships among clinician delay of diagnosis of breast cancer and tumor size, nodal status, and stage",
    abstract = "Background: The objective of this study was to determine the impact of delay of diagnosis by clinicians on breast cancer prognostic factors and survival. Methods: The medical records of patients whose breast cancer diagnosis was delayed by clinicians were reviewed. Data collected included primary tumor diameter, number of positive lymph nodes, tumor grade, pathologic stage, length of diagnostic delay, and follow-up status. Data were analyzed for correlations between prognostic factors and length of delay. The Fisher exact test was used to correlate delay and stage with survival. Results: Forty patients had delays from 3 to 36 months. There were no significant correlations between delay and natural log of primary tumor diameter (r = -.16, P = .33), number of positive lymph nodes (r = .22, P = .90), tumor grade (R = -.16, P = .36), or pathologic stage (R = -.09, P = .59). A higher stage correlated with decreased survival (P = .03), but delay did not. Conclusions: Clinician diagnostic delays of up to 36 months did not correlate with worsening prognostic factors or with survival rates.",
    keywords = "Breast cancer, Delay of diagnosis",
    author = "Chelsea Hardin and Pommier, {Su Ellen Johnson} and Rodney Pommier",
    year = "2006",
    month = "10",
    doi = "10.1016/j.amjsurg.2006.06.027",
    language = "English (US)",
    volume = "192",
    pages = "506--508",
    journal = "American Journal of Surgery",
    issn = "0002-9610",
    publisher = "Elsevier Inc.",
    number = "4",

    }

    TY - JOUR

    T1 - The relationships among clinician delay of diagnosis of breast cancer and tumor size, nodal status, and stage

    AU - Hardin, Chelsea

    AU - Pommier, Su Ellen Johnson

    AU - Pommier, Rodney

    PY - 2006/10

    Y1 - 2006/10

    N2 - Background: The objective of this study was to determine the impact of delay of diagnosis by clinicians on breast cancer prognostic factors and survival. Methods: The medical records of patients whose breast cancer diagnosis was delayed by clinicians were reviewed. Data collected included primary tumor diameter, number of positive lymph nodes, tumor grade, pathologic stage, length of diagnostic delay, and follow-up status. Data were analyzed for correlations between prognostic factors and length of delay. The Fisher exact test was used to correlate delay and stage with survival. Results: Forty patients had delays from 3 to 36 months. There were no significant correlations between delay and natural log of primary tumor diameter (r = -.16, P = .33), number of positive lymph nodes (r = .22, P = .90), tumor grade (R = -.16, P = .36), or pathologic stage (R = -.09, P = .59). A higher stage correlated with decreased survival (P = .03), but delay did not. Conclusions: Clinician diagnostic delays of up to 36 months did not correlate with worsening prognostic factors or with survival rates.

    AB - Background: The objective of this study was to determine the impact of delay of diagnosis by clinicians on breast cancer prognostic factors and survival. Methods: The medical records of patients whose breast cancer diagnosis was delayed by clinicians were reviewed. Data collected included primary tumor diameter, number of positive lymph nodes, tumor grade, pathologic stage, length of diagnostic delay, and follow-up status. Data were analyzed for correlations between prognostic factors and length of delay. The Fisher exact test was used to correlate delay and stage with survival. Results: Forty patients had delays from 3 to 36 months. There were no significant correlations between delay and natural log of primary tumor diameter (r = -.16, P = .33), number of positive lymph nodes (r = .22, P = .90), tumor grade (R = -.16, P = .36), or pathologic stage (R = -.09, P = .59). A higher stage correlated with decreased survival (P = .03), but delay did not. Conclusions: Clinician diagnostic delays of up to 36 months did not correlate with worsening prognostic factors or with survival rates.

    KW - Breast cancer

    KW - Delay of diagnosis

    UR - http://www.scopus.com/inward/record.url?scp=33748433646&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=33748433646&partnerID=8YFLogxK

    U2 - 10.1016/j.amjsurg.2006.06.027

    DO - 10.1016/j.amjsurg.2006.06.027

    M3 - Article

    C2 - 16978961

    AN - SCOPUS:33748433646

    VL - 192

    SP - 506

    EP - 508

    JO - American Journal of Surgery

    JF - American Journal of Surgery

    SN - 0002-9610

    IS - 4

    ER -